Disease management
The Utah-based company will utilize Microsoft's AI technology to expand its machine learning speech models and accelerate AI-enabled speech analysis technology.
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting.
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
Also, HeraMED is deploying its remote pregnancy monitoring solutions in a private practice in Perth.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.
AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring.
The company will use the funds to expand its reach.